Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone methyltransferase.

Allen MD, Grummitt CG, Hilcenko C, Min SY, Tonkin LM, Johnson CM, Freund SM, Bycroft M, Warren AJ.

EMBO J. 2006 Oct 4;25(19):4503-12. Epub 2006 Sep 21.

2.

ZF-CxxC domain-containing proteins, CpG islands and the chromatin connection.

Long HK, Blackledge NP, Klose RJ.

Biochem Soc Trans. 2013 Jun;41(3):727-40. doi: 10.1042/BST20130028. Review.

3.

MLL translocations, histone modifications and leukaemia stem-cell development.

Krivtsov AV, Armstrong SA.

Nat Rev Cancer. 2007 Nov;7(11):823-33. Review.

PMID:
17957188
4.

Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.

Li BE, Ernst P.

Exp Hematol. 2014 Dec;42(12):995-1012. doi: 10.1016/j.exphem.2014.09.006. Epub 2014 Sep 28. Review.

5.

Molecular coupling of DNA methylation and histone methylation.

Hashimoto H, Vertino PM, Cheng X.

Epigenomics. 2010 Oct;2(5):657-69. Review.

6.

The molecular biology of mixed lineage leukemia.

Slany RK.

Haematologica. 2009 Jul;94(7):984-93. doi: 10.3324/haematol.2008.002436. Epub 2009 Jun 16. Review.

7.

Substrate and product specificities of SET domain methyltransferases.

Del Rizzo PA, Trievel RC.

Epigenetics. 2011 Sep 1;6(9):1059-67. doi: 10.4161/epi.6.9.16069. Epub 2011 Sep 1. Review.

8.

CpG island chromatin is shaped by recruitment of ZF-CxxC proteins.

Blackledge NP, Thomson JP, Skene PJ.

Cold Spring Harb Perspect Biol. 2013 Nov 1;5(11):a018648. doi: 10.1101/cshperspect.a018648. Review.

9.

Gene methylation in gastric cancer.

Qu Y, Dang S, Hou P.

Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Review.

10.

Hijacked in cancer: the KMT2 (MLL) family of methyltransferases.

Rao RC, Dou Y.

Nat Rev Cancer. 2015 Jun;15(6):334-46. doi: 10.1038/nrc3929. Review.

11.

Disordered epigenetic regulation in MLL-related leukemia.

Zhang Y, Chen A, Yan XM, Huang G.

Int J Hematol. 2012 Oct;96(4):428-37. doi: 10.1007/s12185-012-1180-0. Epub 2012 Sep 29. Review.

PMID:
23054645
12.

Mixed lineage leukemia: a structure-function perspective of the MLL1 protein.

Cosgrove MS, Patel A.

FEBS J. 2010 Apr;277(8):1832-42. doi: 10.1111/j.1742-4658.2010.07609.x. Epub 2010 Mar 4. Review.

13.

MLL: a histone methyltransferase disrupted in leukemia.

Hess JL.

Trends Mol Med. 2004 Oct;10(10):500-7. Review.

PMID:
15464450
14.

SET domain protein lysine methyltransferases: Structure, specificity and catalysis.

Qian C, Zhou MM.

Cell Mol Life Sci. 2006 Dec;63(23):2755-63. Review.

PMID:
17013555
15.

Targeting epigenetic programs in MLL-rearranged leukemias.

Bernt KM, Armstrong SA.

Hematology Am Soc Hematol Educ Program. 2011;2011:354-60. doi: 10.1182/asheducation-2011.1.354. Review.

PMID:
22160057
Items per page

Supplemental Content

Write to the Help Desk